|
Cash Flow for
ZYMOGENETICS INC
(ZGEN)
|
|
|
|
|
|
|
| Cash Flow |
in Thousands of Dollars |
|
|
| Net Income |
(42,981) |
(116,241) |
(148,144) |
(78,027) |
(88,756) |
| Depreciation |
6,906 |
7,173 |
7,219 |
6,286 |
5,469 |
| Amortization |
1,567 |
877 |
- |
1,022 |
2,679 |
| Amortization of Intagibles |
- |
- |
- |
- |
- |
| Deferred Income Taxes |
- |
- |
- |
- |
- |
| Operating Gains/Losses |
(10) |
(6,876) |
(66) |
2,924 |
9,394 |
| Extraordinary Gains/Losses |
- |
- |
- |
- |
- |
| Decrease in Receivables |
3,577 |
(4,012) |
(1,980) |
1,174 |
(378) |
| Decrease in Inventories |
(34,783) |
(32,391) |
- |
- |
- |
| Decrease in Prepaid Expenses |
(1,464) |
1,025 |
(879) |
(547) |
(509) |
| Decrease in Other Current Assets |
- |
- |
- |
(85) |
(400) |
| Increase in Payables |
5,166 |
(3,118) |
4,054 |
(393) |
911 |
| Increase in Other Current Liabilities |
48,299 |
17,958 |
8,833 |
(14,858) |
38,487 |
| Decrease in Other Working Capital |
84,555 |
138 |
23,354 |
- |
- |
| Other Non-Cash Items |
14,656 |
25,822 |
20,108 |
884 |
1,152 |
| Net Cash from Continuing Operations |
85,488 |
(109,645) |
(87,501) |
(81,620) |
(31,951) |
| Net Cash from Discontinued Operations |
- |
- |
- |
- |
- |
| Cash from Operating Activities |
85,488 |
(109,645) |
(87,501) |
(81,620) |
(31,951) |
|
|
| Sale of Property, Plant, Equipment |
13 |
11,761 |
- |
4 |
88 |
| Sale of Long Term Investments |
- |
- |
- |
- |
- |
| Sale of Short Term Investments |
31,343 |
162,704 |
283,649 |
322,721 |
246,548 |
| Purchase of Property, Plant, Equipment |
(1,801) |
(4,802) |
(6,439) |
(5,687) |
(16,969) |
| Acquisitions |
- |
- |
- |
- |
- |
| Purchase of Long Term Investments |
- |
- |
- |
- |
- |
| Purchase of Short Term Investments |
(25,072) |
(63,397) |
(171,094) |
(360,850) |
(256,835) |
| Other Investment Changes, Net |
- |
- |
- |
- |
- |
| Cash from Investing Activities |
4,483 |
106,266 |
106,116 |
(43,812) |
(27,168) |
| Cash from Discontinued Investing Activities |
- |
- |
- |
- |
- |
|
| Issuance of Debt |
- |
25,000 |
- |
- |
- |
| Issuance of Capital Stock |
1,564 |
454 |
5,045 |
130,446 |
71,908 |
| Repayment of Debt |
- |
- |
- |
- |
- |
| Repurchase of Capital Stock |
- |
- |
- |
- |
- |
| Payment of Cash Dividends |
- |
- |
- |
- |
- |
| Other Financing Charges, Net |
11 |
(1,224) |
- |
- |
6,943 |
| Cash from Financing Activities |
1,575 |
24,230 |
5,045 |
130,446 |
78,851 |
| Cash from Discontinued Financing Activities |
- |
- |
- |
- |
- |
|
|
| Effect of Exchange Rate Changes |
- |
- |
- |
- |
- |
| Net Change in Cash |
91,546 |
20,851 |
23,660 |
5,014 |
19,732 |
|
| Cash at Beginning of Year |
50,088 |
29,237 |
5,577 |
117,308 |
97,576 |
| Cash at End of Period |
141,634 |
50,088 |
29,237 |
122,322 |
117,308 |
| Foreign Sales |
- |
- |
N/A |
N/A |
N/A |
| Domestic Sales |
- |
- |
N/A |
N/A |
N/A |
|
|
|
